Estimation of relative biological effectiveness of <sup>225</sup>Ac compared to <sup>177</sup>Lu during [<sup>225</sup>Ac]Ac-PSMA and [<sup>177</sup>Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRAS.

Publication Year: 2023

DOI:
10.1186/s40658-023-00567-2

PMCID:
PMC10495309

PMID:
37695374

Journal Information

Full Title: EJNMMI Phys

Abbreviation: EJNMMI Phys

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Radiology, Nuclear Medicine & Medical Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot required. Competing interestsThe authors have no relevant financial or non-financial interests to disclose. Consent for publicationNot required. Competing interests The authors have no relevant financial or non-financial interests to disclose."

Evidence found in paper:

"Funding Open Access funding enabled and organized by Projekt DEAL. Mikhail Rumiantcev is funded by the German Research Foundation (DFG) within the Research Training Group GRK 2274. Grigory Liubchenko is funded and Astrid Delker is partially funded by the Federal Ministry of Education and Research (funding number: 02NUK065C)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025